Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of combining vildagliptin with pioglitazone in drug-naive adults with type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes [Phase 3]
This Phase 3 trial comparing vildagliptin with rosiglitazone in drug-naive patients with Type 2 diabetes has completed; the update discusses…
-
CLINICAL_TRIALS withdrawal · 2017-05-17Clinical Trial Update: Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics [NA]
The clinical trial evaluating whether ranolazine reduces biomarkers of myocardial damage in patients with silent myocardial ischemia and typ…
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: STOP DIABETES - Knowledge-based Solutions [NA]
This entry reports a recruiting clinical trial for Type 2 diabetes mellitus evaluating a knowledge-based lifestyle intervention, sponsored b…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy
A completed clinical trial evaluating PRKAA2 genetic polymorphisms and their association with susceptibility to Type 2 diabetes mellitus and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: Developing a Positive Psychology Intervention to Improve Health Behaviors in Type 2 Diabetes: Qualitative Research
The document reports completion of a qualitative study evaluating a positive psychology intervention aimed at improving health behaviors in …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: User Evaluation of the MiniMed 640G Insulin Pump [NA]
A completed clinical trial evaluating the MiniMed 640G insulin pump in individuals with type 1 and type 2 diabetes, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1]
This report documents the completion of a Phase 1 trial evaluating the effect of darapladib on cantharidin-induced inflammatory blisters in …
-
FDA approval · 2017-05-12FDA Approved: GLIPIZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for GLIPIZIDE by Aurobindo Pharma Limited, authorizing a generic formulation of glipizide. The approva…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease [NA]
This clinical trial evaluated the effect of lisinopril on renal blood flow and its relationship to proteinuria reduction in subjects with Ty…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls [Phase 2]
A Phase 2 clinical trial update evaluating how empagliflozin pharmacokinetics affect renal glucose reabsorption in adults with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes [Phase 2, Phase 3]
A pilot Phase 2/3 trial evaluating BMS-512148 in people with type 2 diabetes has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Supplements for Controlling Resistance to Insulin [Phase 4]
Phase 4 trial evaluating supplements to reduce insulin resistance in obesity and type 2 diabetes mellitus was terminated; results were poste…
-
CLINICAL_TRIALS research · 2017-05-10Clinical Trial Update: Lifestyle Improvement Through Food and Exercise (LIFE)Study [NA]
The LIFE Study, a lifestyle intervention trial for Type 2 diabetes mellitus investigating diet and exercise, has completed. Sponsor: Rush Un…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients [Phase 2]
Phase 2 trial evaluating amlexanox versus placebo in type 2 diabetes patients; results completed and posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Lovaza® and Microvascular Function in Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update of Lovaza (omega-3-acid ethyl esters) assessing microvascular function in adults with type 2 diabetes and hype…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills [NA]
A completed clinical trial evaluated a tablet-assisted behavioral intervention aimed at improving self-management skills in adults with Type…
-
FDA approval · 2017-05-08FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (insulin aspart protamine and insulin aspa…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects [Phase 1]
This Phase 1 dose-escalation study evaluated a single subcutaneous dose of NNC 0113-0217 in healthy male volunteers to assess safety, tolera…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Comparing Moderate and High-intensity Interval Training Protocols on Biomarkers in Type 2 Diabetes Patients [NA]
A completed clinical trial comparing moderate- and high-intensity interval training on biomarkers in adults with Type 2 Diabetes, sponsored …
-
CLINICAL_TRIALS research · 2017-05-08Clinical Trial Update: Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)
Clinical trial update focused on establishing the optimum cut-off value for diagnosing Type 2 diabetes mellitus in a Chinese population (SEN…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Cardiorespiratory Fitness Using Electrically Assisted Bicycles [NA]
This completed clinical trial evaluated the effects of electrically assisted bicycles on cardiorespiratory fitness in adults with Type 2 dia…
-
CLINICAL_TRIALS research · 2017-05-08Clinical Trial Update: Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)
Clinical trial evaluating innovated screening tools for Type 2 diabetes mellitus in a Chinese population; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents [Phase 2, Phase 3]
This clinical trial update describes Phase 2/Phase 3 testing of resveratrol for overweight adolescents with NAFLD and insulin resistance. Th…
-
CLINICAL_TRIALS research · 2017-05-05Clinical Trial Update: NYULMC CareSmarts Pilot [NA]
This is a completed clinical trial update for the NYU Langone Health CareSmarts Pilot. The study targets diabetes management, including Type…